Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Silo Pharma (SILO) over the last 11 years, with Q3 2025 value amounting to 6388.16%.

  • Silo Pharma's EBIT Margin fell 7845300.0% to 6388.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 7361.09%, marking a year-over-year decrease of 17356300.0%. This contributed to the annual value of 6526.44% for FY2024, which is 11790300.0% down from last year.
  • Silo Pharma's EBIT Margin amounted to 6388.16% in Q3 2025, which was down 7845300.0% from 6926.77% recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's EBIT Margin registered a high of 574643.9% during Q4 2021, and its lowest value of 10059.65% during Q4 2024.
  • Its 5-year average for EBIT Margin is 30708.67%, with a median of 5265.76% in 2022.
  • In the last 5 years, Silo Pharma's EBIT Margin soared by 2000000000bps in 2021 and then plummeted by 2000000000bps in 2022.
  • Over the past 5 years, Silo Pharma's EBIT Margin (Quarter) stood at 574643.9% in 2021, then crashed by -102bps to 9192.04% in 2022, then grew by 30bps to 6455.81% in 2023, then tumbled by -56bps to 10059.65% in 2024, then surged by 36bps to 6388.16% in 2025.
  • Its last three reported values are 6388.16% in Q3 2025, 6926.77% for Q2 2025, and 6069.68% during Q1 2025.